Serina Therapeutics, Inc.
SER· NYSE
Released Mar 24, 2025, after the close
10-K filed Mar 24, 2025, 83 days after period end · 0001708599-25-000027
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $3.09M | $8.00K | $27.00K |
| Net Income | -$2.74M |
Serina Therapeutics, Inc. · CIK 1708599 · Engraved from SEC EDGAR
| $1.05M |
| -$2.70M |
| -$2.16M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.